On April 1, 2026, the U.S. Food and Drug Administration approved Foundayo (orforglipron) — Eli Lilly’s once-daily oral pill for obesity. The approval came in a record-breaking 50 days, the fastest for any… Continue Reading
Blogs
The ‘Mounjaro Bride’ Is Real And She Deserves Better
A new trend has a name now: the “Mounjaro bride.” Across Indian cities, women preparing for their weddings are turning to tirzepatide and semaglutide injections — the same GLP-1 drugs… Continue Reading
Semaglutide Price in India (2026): Generic Brands, Manufacturers & Cost Comparison
Introduction March 20, 2026, marked a turning point in Indian healthcare. On that date, the patent on semaglutide — the active molecule behind blockbuster weight-loss and diabetes drugs Ozempic and… Continue Reading
Weight Loss Drugs in India 2025–2026
Introduction India is in the middle of a quiet but profound health revolution. For decades, weight loss advice followed a familiar script eat less, move more, be patient. But in… Continue Reading
17 Cancer Drugs Just Became Duty-Free. Here’s What That Actually Changes
Finance Minister Nirmala Sitharaman’s customs duty wipeout on life-saving oncology medicines is making headlines — but the real story is in the details patients actually care about. India has roughly… Continue Reading